Triall

📍 Maarssen, Netherlands🗓 Founded 2018👥 19 employees💰 Last funded Feb 2020
IT Services and IT Consulting🌐 triall.io
Website LinkedIn
Triall’s mission is to enable a future of smarter, safer, and more-efficient clinical trials by leveraging the latest emerging technologies. We offer a modular and fully-integrated suite of clinical trial software (eClinical) solutions for all core study functions, including EDC, ePRO/eCOA, eSource, eConsent, eTMF, CTMS, RTSM, Wearable integration, and more. Triall’s end-to-end platform is designed to support any therapeutic area, any trial type (decentralised, hybrid, site-based), and any trial phase (I-IV). Moreover, we apply blockchain to generate verifiable proof of the integrity of clinical trial data and leverage Self-Sovereign Identity (SSI) technologies to provide patients and clinicians with more ownership and control over their data, documents, and processes. Check out our website triall.io or reach out to our team at contact@triall.io to learn more about our platform and technologies.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Triall?
Triall has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Triall last raise funding?
The most recent investment in Triall recorded on gritt.io was in February 2020.
When was Triall founded?
Triall was founded in 2018.
What industry is Triall in?
Triall operates in IT Services and IT Consulting. Find similar IT Services and IT Consulting investors on gritt.io.
Where is Triall based?
Triall is headquartered in Maarssen, Netherlands.